Delivery Order SPE2DB24D9802-SPE2DB25FJKWU
Award Date
4/30/25
Potential Completion Date
5/21/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,567,979,703 units of Nexplanon 68 mg implants, a contraceptive device, with a ceiling value of $33,326.88. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4,567,950 units of the contraceptive implant Nexplanon 68 mg, with a ceiling value of $3,471.55. The contract has an ultimate completion date of May 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4,567,978,095 units of the Nexplanon 68 mg implant, a contraceptive device, with a ceiling value of $24,995.16 and a performance period ending on May 6, 2025. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,143 units of the Nexplanon 68 mg implant, a long-acting reversible contraceptive device, with a total ceiling value of $20,829.30. The contract has an ultimate completion date of May 20, 2025 and was awarded on April 29, 2025. DMS...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the delivery of 4,561,996,098 units of the contraceptive implant Nexplanon 68 mg. The contract has a ceiling value of $3,418.70 and a completion date of September 14, 2023. DMS Pharmaceutical Group holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract, valued at $102,915.36, is for the delivery of Nexplanon 68 mg implants, a contraceptive device. The contract has a performance period ending on March 18, 2024. DMS Pharmaceutical Group Inc. is an experienced pharmaceutical wholesaler that has held multiple prime vendor contracts with the Department of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $6,943.10, is for the delivery of 4,567,998,788 units of the contraceptive device NEXPLANON 68 MG IMPLANTS. The contract has an ultimate completion date of May 12, 2025 and was awarded on April 21, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has secured a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $4,165.86, is for the delivery of 4,568,160,649 units of the Nexplanon 68 mg contraceptive implant. The contract is a firm fixed-price delivery order with a completion date of May 23, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,573.45, is for the delivery of Nexplanon 68 mg implants. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a ceiling value of $17,357.75 and an ultimate completion date of March 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...